MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202611084209 A) filed by Dr. Arun Kumar Mishra; Dr. Ravi Kant; Prof. Prashant Singh; Dr. Anindita Bhattacharya; Dr. Asha Singh; Dr. Ashish Kumar; Digvijaya Saini; Dr. Mamta Belwal; and Ajay Dixit on July 09, 2026, for Ai-Based Chemical Compound Screening System For Pharmaceutical Applications.
Inventors include Dr. Arun Kumar Mishra; Dr. Ravi Kant; Prof. Prashant Singh; Dr. Anindita Bhattacharya; Dr. Asha Singh; Dr. Ashish Kumar; Digvijaya Saini; Dr. Mamta Belwal; and Ajay Dixit.
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: The present invention discloses an artificial intelligence based chemical compound screening system (100) for pharmaceutical applications. The system (100) comprises an input interface module (110), a compound database repository (120), a molecular descriptor extraction module (130), an artificial intelligence screening engine (140) having a feature extraction sub-module (142), a deep learning neural network (144) and a QSAR prediction sub-module (146), a target interaction prediction module (150), an ADMET property prediction module (160), a scoring and ranking module (170), an output and visualization module (180) and a feedback learning module (190) executed by a processor (200) coupled to a memory unit (210) and a communication interface (220). The feedback learning module (190) retrains the deep learning neural network (144) using experimental validation data in a closed loop, thereby progressively improving screening accuracy across successive cycles.
Disclaimer: Curated by HT Syndication.
